Correlation between anti-müllerian hormone in polycystic ovarian syndrome with metformin: a systematic review and meta-analysis.

Hongcen LiuLi MoXiaofang TianShizhen FanJiayi HuLin ZhangBohai Yu

Published in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2024)

The results of this meta-analysis indicate that MET treatment exerts a suppressive effect on serum AMH levels in women with PCOS. It appears that a treatment duration of at least three months is required to achieve a significant decrease in AMH concentrations. Furthermore, the influence of MET on AMH is dose-dependent, with higher doses correlating with more pronounced reductions in AMH levels among the patients studied.

Keyphrases

systematic review
end stage renal disease
chronic kidney disease
ejection fraction
tyrosine kinase
randomized controlled trial
metabolic syndrome
case report
adipose tissue
combination therapy
meta analyses
replacement therapy